NAT10-Mediated ac4C-Modification Exacerbates Ferroptosis by Stabilizing HMOX1 in Deep Vein Thrombosis
Top Cited Papers
Open Access
- 1 February 2026
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (2) , e323986
Abstract
BACKGROUND: Deep vein thrombosis (DVT) is a prevalent peripheral vascular disorder associated with abnormal epigenetic processes and altered gene expression in endothelial cells. Accumulating evidence has demonstrated that NAT10 ( N -acetyltransferase 10)–mediated N 4-acetylcytidine modification exerts unique roles in ferroptosis, but its roles are still elusive in DVT. METHODS: To explore the potential mechanism of NAT10 and ferroptosis on thrombogenesis, we used NAT10 and GPX4 (glutathione peroxidase 4) knockout mice as an in vivo model, and utilized techniques, such as RNA immunoprecipitation, acRIP-qPCR (acetylated RNA immunoprecipitation-quantitative PCR), N 4-acetylcytidine Dot Blotting assay, and Western blotting, for detailed molecular analysis. RESULTS: GPX4 is a pivotal gene that suppresses ferroptosis. Utilizing endothelial cell–specific GPX4 conditional knockout mice (GPX4 fl/fl Cdh5-Cre + ), we proved that ferroptosis in endothelial cells promotes the formation of thrombosis. Previous evidence indicates that NAT10 overexpression induces ferroptosis and downregulates GPX4 expression. Here, we found that NAT10 expression was elevated in DVT mice, and silencing of NAT10 markedly attenuated ferroptosis both in vitro and in vivo. Furthermore, endothelial cell–specific knockout of NAT10 (NAT10 fl/fl Cdh5-Cre + ) demonstrated a reduction in endothelial ferroptosis, thereby inhibiting both the formation and progression of DVT. Mechanistic studies indicated that NAT10 facilitated the N4-acetylcytidine modification of HMOX1 (heme oxygenase 1), which enhanced its mRNA stability, leading to the accumulation of ferrous ions, and exacerbating endothelial dysfunction in DVT. CONCLUSIONS: Collectively, our data elucidate that downregulation of NAT10 mitigates endothelial ferroptosis and prevents DVT formation and progression by modulating HMOX1 expression, which offers a potential novel strategy for the prevention and treatment of thrombosis in DVT.Keywords
This publication has 50 references indexed in Scilit:
- Advances of NAT10 in diseases: insights from dual properties as protein and RNA acetyltransferaseCell Biology and Toxicology, 2024
- Blocking of FGFR4 signaling by F30 inhibits hepatocellular carcinoma cell proliferation through HMOX1-dependent ferroptosis pathwayEuropean Journal of Pharmacology, 2024
- UCHL1 deficiency upon HCMV infection induces vascular endothelial inflammatory injury mediated by mitochondrial iron overloadFree Radical Biology and Medicine, 2023
- Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challengesBiochemical Pharmacology, 2023
- N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNACancer Communications, 2022
- NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myelomaActa Pharmaceutica Sinica B, 2022
- Hemodynamics mediated epigenetic regulators in the pathogenesis of vascular diseasesMolecular and Cellular Biochemistry, 2020
- Nobiletin Regulates ROS/ADMA/DDAHII/eNOS/NO Pathway and Alleviates Vascular Endothelium Injury by Iron OverloadBiological Trace Element Research, 2020
- Hmox1 promotes osteogenic differentiation at the expense of reduced adipogenic differentiation induced by BMP9 in C3H10T1/2 cellsJournal of Cellular Biochemistry, 2018
- Mouse models of deep vein thrombosisGefässchirurgie, 2016